跳至主要内容
临床试验/NCT04917185
NCT04917185Unknown不适用

Electro-acupuncture for Protracted Amphetamine Abstinence Syndrome : A Pragmatic Randomized Controlled Trial

Chengdu University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
1
主要终点
Amphetamine Cessation Symptom Assessment

研究概览

简要总结

In 2019, around 27 million people worldwide, corresponding to 0.5% of the adult population, have used amphetamine-type stimulants (ATS). More than one-third of these 27 million users of ATS were in East and South-East Asia. ATS are a group of synthetic psychostimulants including methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and related substances. Although the biology underlying amphetamine withdrawal syndrome is not fully understood, amphetamine has been shown to produce long-lasting reductions in neuronal expression of dopamine neuronal markers. Abuse of these synthetic psychostimulants can lead to drug addiction, and subsequent withdrawal can cause a series of mental symptoms, such as anxiety, depression, confusion, insomnia, mood disturbances, cognitive impairments, and delusions. Some studies have shown two clear stages of ATS withdrawal syndrome: an acute phase lasting 7-10 days, and a subacute phase lasting a further 2 weeks or more, which is termed called "Protracted amphetamine abstinence syndrome (PAAS)".

The relevant literature has indicated that the majority of patients with ATS withdrawal disorders can experience depression, cognitive impairments, insomnia, and anxiety, especially during the PAAS stage. These symptoms may affect the treatment and finally lead to a relapse. Nowadays, pharmacological therapies are mostly symptom-targeted and show an ungratified effectiveness for amphetamine-type drugs. There is no a medication approved by Food and Drug Administration for use in the treatment of methamphetamine addiction. Therefore, the treatment of PAAS is essential for the treatment of ATS use disorders.

Traditional Chinese medicine (TCM), especially acupuncture, is effective in the treatment of withdrawal symptoms with few side effects. research on acupuncture detoxification originates from the treatment of opioid drug withdrawal. Studies have shown that acupuncture has high efficacy in the treatment of protracted abstinence symptoms after heroin addiction. This study hypothesizes that acupuncture has the same mechanism of action in the treatment of PAAS as in the treatment of protracted opioid abstinence syndrome. Therefore, investigators have designed a real-world-based pragmatic randomized controlled trial (pRCT) to determine the effectiveness of acupuncture in the treatment of PAAS and provide support for clinical decision-making.

Investigators conduct a pragmatic randomized controlled trials(pRCT) to observe the effect of acupuncture in a larger sample. It combines the advantages of randomization and real-world data, and the results can provide the best real-world evidence for the assessment of intervention effects or comparative effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients meet the diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (21);
  • A urine test for methamphetamine is negative.
  • 18-60 years old, male or female, conscious, no aphasia, or mental retardation, primary school education or above, and able to understand the contents of the scales and cooperate with treatment;
  • Did not participate in other clinical trials within 3 months;
  • Signed the informed consent from.

排除标准

  • Local trauma or infected persons who have received EA;
  • Can' not tolerate EA, EA treatment, or allergic to EA needles;
  • Pregnant or breastfeeding women;
  • Serious disorders of the heart, liver, or kidney, or suicidal tendencies.

结局指标

主要结局

Amphetamine Cessation Symptom Assessment

时间窗: Change from baseline Amphetamine Cessation Symptom Assessment scores at 1 month.

It consists of three subscales, namely, "anxiety and mood", "fatigue", and "craving". Items are scored on a five-point scale ranging from 0 to 4 with higher scores representing more severe Amphetamine Cessation Symptom

次要结局

  • Hamilton Anxiety Scale(Change from baseline Hamilton Anxiety Scale scores at 1 month.)
  • Visual Analog Scale(Change from baseline Visual Analog Scale scores at 1 month.)
  • 36-item Short Form Health Survey(Change from baseline 36-item Short Form Health Survey scores at 1 month.)
  • Hamilton Depression Scale(Change from baseline Hamilton Depression Scale scores at 1 month.)
  • Pittsburgh Sleep Quality Index(Change from baseline Pittsburgh Sleep Quality Index scores at 1 month.)

研究者

发起方
Chengdu University of Traditional Chinese Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ren Yu-Lan

professor

Chengdu University of Traditional Chinese Medicine

研究点 (1)

Loading locations...

相似试验